UNC13A
- 1 trial
- 1 of 1 trial sponsored by developers of drugs on it
- Humans1
- Cells1
Latest
1 in 12 monthsJournal of Neurology, Neurosurgery, and Psychiatry
Associations of self-reported and objectively measured physical activity and amyotrophic lateral sclerosis risk
Cohort study of 384,836 peopleAmyotrophic lateral sclerosis
Experimental Neurology
Modeling of TDP-43 proteinopathy by chronic oxidative stress identifies rapamycin as beneficial in ALS patient-derived 2D and 3D iPSC models
Experiments in human cellsRapamycin